Full-Time
Hardware Architect
Zeiss
1,001-5,000 employees
Corporate venture capital for deep-tech startups
No salary listed
Bengaluru, Karnataka, India
In Person
Bachelor's, Master's
 Hardware Engineering (2) |
|---|
| , |
Get referred to Zeiss
See people who can refer or advise you
- A Bachelor's or Master's degree in Electronics Engineering, Electrical Engineering, Biomedical Engineering, or a related field is required.
- Typically 12+ years of experience in hardware engineering is required, preferably in medical devices or regulated industries.
- Proven experience developing complex embedded hardware systems across the product lifecycle is required.
- Experience working in cross-functional and global development environments is required.
- Strong expertise in embedded hardware architecture and system design is required.
- Deep knowledge of analog design, including signal conditioning, analog-to-digital and digital-to-analog conversion, and power circuits, is required.
- Experience with value engineering in hardware engineering is required.
- Knowledge of digital design involving microcontrollers and processors is required; FPGA knowledge is a plus.
- Experience in electrical design, schematic development, and hardware validation is required.
- A solid understanding of hardware-software integration and embedded systems is required.
- Familiarity with communication protocols including SPI, I2C, UART, and Ethernet is required.
- Understanding of mechanical integration, including sheet metal and plastic components, is required.
- Knowledge of regulatory and compliance standards in medical device development is required.
- Strong troubleshooting, debugging, and problem-solving skills are required.
- Good knowledge of electromagnetic compatibility, safety standards, and reliability engineering is required.
- Define and evolve scalable, reliable, and maintainable hardware architectures for medical devices.
- Lead the design and development of embedded hardware systems, ensuring optimal performance, power efficiency, and system integration.
- Develop system-level architectures covering electronics, embedded platforms, sensors, optical interfaces, and connectivity.
- Ensure seamless interaction between hardware, embedded software, and higher-level application systems.
- Design and validate complex electrical systems, including analog circuits for signal conditioning, sensor interfacing, and power management, as well as digital systems using microcontrollers, processors, and communication interfaces.
- Develop schematics and PCB layouts in collaboration with design teams, and perform design reviews.
- Ensure compliance with relevant electromagnetic compatibility, safety, and regulatory requirements.
- Drive hardware bring-up, debugging, and root cause analysis during development and field issues.
- Define and support embedded architecture, including processor selection, interfaces, and hardware-software partitioning.
- Work closely with software teams to ensure efficient hardware-software integration.
- Enable reliable communication between sensors, actuators, and processing units.
- Ensure system performance, real-time behavior, and diagnostic capabilities.
- Collaborate with mechanical engineering teams on device integration and ensure hardware compatibility with sheet metal components, plastic enclosures, and assemblies.
- Consider thermal management, structural constraints, manufacturability, and serviceability in hardware design.
- Work closely with product management, systems engineering, optics, usability, quality, and manufacturing teams.
- Translate clinical, customer, and business requirements into hardware specifications and designs.
- Ensure alignment with system architecture and product timelines.
- Support system-level integration and validation activities.
- Collaborate with original equipment manufacturer partners for hardware module sourcing, customization, and integration.
- Define technical requirements and specifications for original equipment manufacturer-supplied components.
- Support original equipment manufacturer qualification processes, including design reviews, validation, and compliance checks.
- Ensure original equipment manufacturer deliverables meet quality, reliability, and regulatory requirements.
- Drive issue resolution and continuous improvement with original equipment manufacturer partners.
- Apply value engineering to optimize product cost without compromising quality, performance, or compliance.
- Identify cost drivers in hardware design and drive design-to-cost initiatives.
- Evaluate alternative components, materials, and design approaches to achieve an optimal cost-performance balance.
- Collaborate with sourcing, manufacturing, and original equipment manufacturer partners to achieve cost targets across the product lifecycle.
- Ensure adherence to medical device development processes and regulatory standards.
- Support risk management activities such as hazard analysis and failure mode and effects analysis.
- Maintain documentation, traceability, and configuration management.
- Ensure hardware design supports product reliability, diagnostics, and long-term serviceability.
- Partner with global research and development, quality, regulatory, service, manufacturing, and product teams.
- Translate product strategies into scalable and supportable software solutions.
- Drive collaboration across geographies and disciplines.
- Strengthen software development as an enabler of innovation and customer value.
- Experience in medical devices or regulated industries is preferred.
- Knowledge of field-programmable gate arrays is a plus.
ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, investing in deep-tech startups in Information Technology, Industrial Tech, MedTech, and Life Sciences. It backs early-stage companies at pre-Series A to Series A with typical investments of $1–5 million. The fund provides capital and tailored funding solutions, leveraging ZEISS’s global network and optics/optoelectronics expertise to support portfolio companies. Its goal is to accelerate the development of new technologies and business models that complement ZEISS’s portfolio while actively engaging with external innovation.
Company Size
1,001-5,000
Company Stage
Growth Equity (Non-Venture Capital)
Total Funding
$67.7M
Headquarters
Oberkochen, Germany
Founded
2001
Get referred to Zeiss
See people who can refer or advise you
Simplify's Take
What believers are saying
- ZEISS led Maculaser's May 2026 round for retinal laser therapy commercialization.
- ZEISS Ventures led SeeTrue's €2.2 million round on August 6, 2026.
- ZEISS launched ClearMind lenses and DuraVision Plus in January 2026, reinforcing optical leadership.
What critics are saying
- Carl Zeiss Meditec cut 2026 revenue 5.7% and targets 1,000 job reductions.
- ZEISS's 2026 restructuring threatens innovation velocity and employee morale through 2028/29.
- A prolonged MedTech slump or failed turnaround would weaken ZEISS Ventures' strategic value.
What makes Zeiss unique
- ZEISS Ventures pairs capital with ZEISS distribution, engineering, and ophthalmology channels.
- Its 2026 deals target eye health, imaging, and optoelectronics adjacencies.
- ZEISS brand credibility de-risks pilots for startups selling into regulated healthcare.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Paid Vacation
Performance Bonus
Company News
ZEISS Ventures led a €2.2 million investment round in SeeTrue Technologies, a Finnish deep-tech company developing miniaturised eye-tracking technology. The funding will accelerate commercialisation of SeeTrue's ultra-low-power eye-sensing architecture for next-generation interfaces in smart optical systems and eyewear. SeeTrue's proprietary technology combines miniaturised sensing hardware with optimised embedded processing, enabling scalable eye-sensing capabilities with low power consumption and small hardware footprint. The technology supports gaze-based interaction and attention-aware computing across healthcare, industrial, and smart eyewear applications. The investment round includes participation from Superhero Capital and North Karelia Growth Fund, managed by Redstone Nordics. Founded in 2018 and based in Joensuu, Finland, SeeTrue develops ultra-miniature eye-tracking technology for medical optical systems, vision care, and smart wearables.
ZEISS Medical Technology has announced successful early clinical implantations of its AT LUCIA toric 721P intraocular lens, designed to treat cataracts whilst correcting astigmatism. The company is conducting an early-access clinical trial with experienced surgeons across six European countries. The lens combines an aspheric bitoric optic with a patented non-constant aberration design on a fully preloaded, hydrophobic platform. Surgeons have reported positive early impressions, highlighting the lens's precision, stability and surgical handling. Currently CE marked, the AT LUCIA toric 721P will be showcased at the International Congress of German Ophthalmic Surgery in Nuremberg from 18–20 June 2026. The lens is expected to be commercially available in select European countries later this year.
ZEISS Ventures has invested in Maculaser, a Finnish medtech company developing temperature-controlled retinal laser therapy, through a funding round co-led with M2care. The investment will support clinical development of the company's personalized treatment for retinal diseases. Founded in 2020 and based on research from Aalto University, Maculaser has developed patented technology that provides real-time temperature control during laser treatment. The non-damaging approach activates natural cellular defence mechanisms, targeting affected retinal areas early to delay or prevent progression of age-related macular degeneration and diabetic maculopathy. The technology aims to shift retinal care from managing late-stage damage to proactive vision preservation, offering an outpatient procedure that integrates into regular eye care. Maculaser plans to bring the treatment into clinical practice to benefit millions of patients worldwide.
ZEISS Medical Technology has received approval from Mexico's COFEPRIS for two ophthalmic surgical devices: the ARTEVO 850 microscope and MICOR 700 lens removal device. Both technologies are compatible with ZEISS's latest cataract workflow systems. The ARTEVO 850 is a 3D heads-up ophthalmic microscope offering true colour imaging and a nearly 60% increase in depth of field. The MICOR 700 is the first handheld lens removal device with ultrasound-free operation, using ZEISS's non-ultrasonic lens extraction procedure to minimise risk to surrounding eye structures. The products will be showcased at the Mexican Congress of Ophthalmology in Monterrey from 30 May to 3 June 2026. ZEISS Medical Technology generated revenue of €2,066.1 million in fiscal year 2023/24.
Hypervision Surgical, a UK-based pioneer in real-time hyperspectral imaging for surgery, has raised £17 million in an oversubscribed Series A round led by Heal Capital. Angelini Ventures participated alongside IP Group and Daycrest, with Angelini Ventures Managing Director Tanja Dowe joining the board. The King's College London spin-out has developed the Hyperspectral Intelligence platform, which combines hyperspectral sensing with AI-driven analytics to provide real-time, quantitative insights into tissue physiology during surgery. The technology captures information beyond what conventional surgical cameras can perceive, potentially improving intraoperative decision-making and reducing complications. The funding will support commercial deployment, clinical adoption and development of next-generation hyperspectral sensing technology. The company's HYPERSNAP system is certified in the UK and cleared by the US FDA.